Skip to main content

Psoriasis Endorsed Content

Lauren Mateja, Managing Editor
It is hypothesized that psoriatic arthritis is too often underdiagnosed, and therefore undertreated, in dermatology. In an interview with The Dermatologist, Drs Joseph F. Merola and Alice B. Gottlieb shared their insights as dual dermatologist-rheumatologists on screening for psoriatic arthritis in the patient with psoriasis.
Lauren Mateja, Managing Editor
Psoriasis can affect patients at all walks of life, from children to the elderly. Adolescents, however, require special considerations, from psychosocial conditions to therapy options, for the short- and long-term management of psoriasis.
Melissa Weiss, Associate Editor
The American Academy of Dermatology and National Psoriasis Foundation released new guidelines on the use of phototherapy for the treatment of psoriasis. Joel Gelfand, MD, MSCE, discussed the updated guidelines with The Dermatologist.
Melissa Weiss, Associate Editor
Recent updates address the latest evidence on the safety and efficacy of biologics.
Peter D. Zang; Donovan G. Kearns; Vipawee S. Chat; Jashin J. Wu, MD
Dermatologists may soon have 2 more FDA-approved drugs for effectively controlling plaque psoriasis.
Olivia Wind and Jeffrey Weinberg, MD
Psoriatic nails are a common, but often overlooked, occurrence in psoriasis patients. Here is the latest on how different medications stack up in treating them.
Melissa Weiss, Associate Editor
A review of recent news, research, and treatment related to psoriasis.
Megan H. Noe, MD, MPH, MSCE
This article focuses on the baseline risk of malignancy, risks associated with treatments for psoriasis, and management strategies for patients with psoriasis and a history of malignancy.
Lawrence Green, MD
This article discusses the latest evidence on oral molecules for the treatment of psoriasis and psoriatic arthritis.
Melissa Weiss, Associate Editor
A review of recent news, research, and treatment related to psoriasis.
Back to Top